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ABSTRACT
OBJECTIVE: This study investigated the effects of chronic melatonin treatment on gene expression of α1-, α2-, 
β1- and β2-adrenoceptors in the hippocampus of rats subjected to chronic unpredictable mild stress (CUMS). 
BACKGROUND: Preclinical studies have also shown that melatonin prevented short- and long-term memory 
impairments and exhibited antidepressant-like actions. 
METHODS: For this study, we used 24 animals, which were divided into four groups, and the experiment lasted 
4 weeks. We quantifi ed the changes in mRNA and protein levels of α1-, α2-, β1- and β2-adrenoceptors in the 
hippocampus after melatonin treatment. 
RESULTS: Our results demonstrated a decreased gene expression of α1-, α2- and β2-adrenoceptors in the hip-
pocampus of rats subjected to unpredictable chronic mild stress, while there was no change in gene expression 
of β1-adrenoceptors. Melatonin treatment in the CUMS rats prevented the stress-induced decrease in mRNA 
and protein levels of α1-and β2-adrenoceptors, whereas did not affect either on mRNA or protein level of β1-and 
α2-adrenoceptors. 
CONCLUSION: Our data suggest that melatonin, by increasing reduced levels of α1- and β2-adrenoceptors mRNA 
and protein in the hippocampus of chronic stressed rats, may be benefi cial in conditions such as chronic stress 
and provides an experimental opportunity to probe into further molecular mechanisms underlying the regulation 
of these receptor subtype (Fig. 2, Ref. 28). Text in PDF www.elis.sk.
KEY WORDS: melatonin, hippocampus, catecholamines, α-adrenoceptors, β-adrenoceptors, chronic stress.
Institute of Nuclear Sciences “VINCA”, Laboratory of Molecular Biology 
and Endocrinology, University of Belgrade, Belgrade, Serbia 
Address for correspondence: S. Dronjak, PhD, Institute of Nuclear Scien-
ces “Vinca”, Laboratory of Molecular Biology and Endocrinology, P.O.B. 
522-090, 11000 Belgrade, Serbia.
Phone/Fax: +381112455561
Acknowledgement: This work was supported by the Ministry of Educa-
tion, Science and Technological Development of the Republic of Serbia, 
Contract nos. 173044.
Introduction
Melatonin is a neurohormone primarily synthesized by the 
pineal gland during darkness (1) with a well-established role in 
regulating seasonal and circadian rhythms. Renewed attention has 
been given to the role of melatonin in modulating behavior, im-
mune system, and responses to stress, cancer and aging (2). Also, it 
has been proved that melatonin had anti-infl ammatory and antioxi-
dant action (3). Preclinical studies have also shown that melatonin 
prevented short- and long-term memory impairments induced by 
chronic sleep deprivation and exhibited antidepressant-like ac-
tions (4, 5). Of the many brain regions affected in depression, the 
hippocampus is well known for its role in cognition stress sensiti-
vity to emotional and memory impairments (6, 7). Hippocampus is 
sensitive to stress, which activates noradrenaline terminals deriv-
ing from the locus coeruleus (8). Activation of the noradrenergic 
system may play an important integrative function in coping with 
and adapting to stress. Adrenergic receptors (α- and β-subtypes) are 
the basic targets of noradrenaline, especially in mediating sympa-
thetic activation in central nervous system. It has been proposed 
that these receptors trigger similar changes in the CNS during a 
successful adaptation to chronic stress and antidepressant therapy 
to yield adaptive changes in neural output or plasticity (6).
There are reports concerning the changes in the density of 
adrenoceptors in depressed individuals. Postmortem studies on 
brains of suicide victims indicated an increase in cortical α1- and 
α2-adrenoceptors (9, 10). β-adrenoceptors have also been im-
plicated in the pathophysiology of depression. Several studies 
support the thesis that the activation of β1- and β2-adrenoceptors 
in the CNS leads to antidepressant-like effect (11, 12). De Paer-
mentier and co-workers (13) showed a decreased density of corti-
cal β-adrenoceptors in the antidepressant-free depressed suicide 
victims. There is no information regarding the direct action of 
melatonin on the expression of α- and β-adrenergic receptors in 
hippocampus of chronically stressed rats. CUMS is currently re-
garded by many investigators as one of the most naturalistic and 
predictive animal models of depression. 
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In this context, we investigated the effects of chronic melato-
nin treatment on gene expression of α1-, α2-, β1- and β2-adrenergic 
receptors in the hippocampus of rats subjected to CUMS.
Methods 
The experiment was performed on male Wistar rats (11 weeks 
old, 250–310 g). The care was taken to minimize the pain and dis-
comfort of the animals according to the guidelines of the Ethical 
Committee for the use of laboratory animals of the “Vinca” Insti-
tute based on EU directive 2010/63EU. 
For this study, we used 24 animals, which were divided into 
four groups. First group was control (unstressed). animals re-
ceived injection of vehicle daily (0.9 % NaCl containing 5 % 
ethanol). Second group was control (unstressed) and animals re-
ceived melatonin. Third group was chronic unpredictable mildly 
stressed group. The animals from this group also received vehicle. 
In the fourth group were chronic unpredictable mildly stressed 
animals, also receiving melatonin. Melatonin was given in dose 
of 10 mg/kg body weight by intraperitoneal (i.p.) route, between 
2:00 and 3:00 p.m. 
The chronic unpredictable mild stress (CUMS) procedure was 
a variation of methods described by Grippo et al (14). The day 
after the CUMS procedure, all animals were sacrifi ced by decapi-
tation, hippocampus was quickly removed on ice, frozen in liquid 
nitrogen and stored at –70 °C until it was analyzed.
Total RNAs from hippocampal tissue was extracted using 
TRIzol® Reagent (Thermo Fischer Scientifi c, MA USA) accord-
ing to the manufacturer’s instructions. Reverse transcription was 
performed using Ready-To-Go You-Prime First-Strand Bead (GE 
Fig. 1. Effect of chronic melatonin treatment on a) alpha 1 adrenoceptor (α1-AR) and b) alpha 2 adrenoceptor (α2-AR) gene expression in the 
hippocampus of rats exposed to CUMS for 28 days. The relative mRNA levels for α1-AR and α2-AR were determined by applying RT-PCR. 
The fi nal result was expressed as fold change relative to the calibrator and normalized to cyclophilin A for variation between samples. α1-AR 
and α2-AR protein levels were determined by Western immunoblotting. The fi nal result was expressed in arbitrary units and normalized in 
relation to β-actin. The values are expressed as the mean ± S.E.M. of 6 rats. Statistical signifi cance: * p < 0.05; ** p < 0.05 CUMS vs control; # p 
< 0.05 placebo vs melatonin.
a b
Stefanovic B et al. Melatonin modulate the expression of α1- and β2-adrenoceptors in the hippocampus… 
xx
431
Healthcare Life Sciences, PA USA) and pd (N)6 primer according 
to manufacturer’s protocol. Real-Time RT-PCR assay was done 
exactly as previously described by Gavrilovic et al (15). TaqMan 
PCR reaction was carried out using Assay-on-Demand Gene Ex-
pression Products (Thermo Fischer Scientifi c, MA USA) for β1 
(ID:Rn00824536_s1) and for β2 (ID:Rn005606650_s1), for α1 
(ID:Rn00567876_m1), and for α2 (ID:Rn00562488_s1). A refer-
ence endogenous control was included in each analysis to correct 
the differences in the inter-assay amplifi cation effi ciency and all the 
transcripts were normalized to cyclophyline A (ID:Rn00690933) 
expression. Hippocampal tissue wase homogenized in RIPA Lysis 
Buffer System (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, 
sc-24948). After centrifugation (12 000rpm, 20 min at 4 °C), the 
supernatant was taken and protein concentration was determined 
by the method of Lowry et al (16). For measuring α1, α2, β1 and 
β2 protein levels, a polyclonal anti-α1 primary antibody, rabbit 
(sc28982, dilution 1:500, Santa Cruz Biotecnology, California, 
USA), a polyclonal anti-α2 primary antibody, rabbit (sc28983, di-
lution 1:500, Santa Cruz Biotechnology, California, USA), poly-
clonal anti-β1 primary antibody, rabbit (ab3442, dilution 1:1000, 
Abcam, Cambridge, UK) and polyclonal anti-β2 primary antibody, 
rabbit (ab182136, dilution 1:1000 Abcam, Cambridge, UK) were 
used respectively. Rabbit polyclonal anti-β-actin (dilution 1:1000; 
Abcam, Cambridge, UK) was used to detect β- actin as a loading 
control. Washed membrane was further incubated in the horse-
radish peroxidase conjugated secondary anti-rabbit antibody for 
luminol based detection (ab6721, dilution 1:5000, Abcam, Cam-
bridge, UK). Secondary antibody was then visualized by Immobil-
Fig. 2. Effect of chronic melatonin treatment on a) beta 1 adrenoceptor (β1-AR) and b) beta 2 adrenoceptor (β2-AR) gene expression in the hip-
pocampus of rats exposed to CUMS for 28 days. The relative mRNA levels for β1-AR and β2-AR were determined by applying RT-PCR. The 
fi nal result was expressed as fold change relative to the calibrator and normalized to cyclophilin A for variation between samples. β1-AR and 
β2-AR protein levels were determined by Western immunoblotting. The fi nal result was expressed in arbitrary units and normalized in rela-
tion to β-actin. The values are expressed as the mean ± S.E.M. of 6 rat s. Statistical signifi cance: * p < 0.05; ** p < 0.05 CUMS vs control; # p < 
0.05; ## p < 0.01 placebo vs melatonin.
a b
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ion Western Chemiluminescent HPR Substrate (Merck Millipore, 
Massachusetts, USA). Western blot analysis was performed as 
previously described by Gavrilovic et al (15).
Statistical analysis
The results are reported as the mean ± S.E.M. Signifi cance of 
the differences in gene expression levels of the examined α1, α2, 
β1, and β2-adrenergic receptors in hippocampus of rats subjected 
to CUMS and melatonin treatment were estimated by Two-Way 
ANOVA test. The Tuckey post hoc test was used to evaluate the 
differences between the groups. Statistical signifi cance was ac-
cepted at p < 0.05. Results processing was done in the OriginPro, 
version 8.0 software program (OriginLab Corporation, Massa-
chusetts, USA).
Results 
The α1-adrenoceptor (F(1,23) = 16.04, p < 0.001) and α2-
adrenoceptor (F(1,23) = 14.64, p < 0.01) mRNA levels were sig-
nifi cantly infl uenced by stress. Compared to the control group, a 
decrease was observed in α1-adrenoceptor (by 50 %, p < 0.001) 
and α2-adrenoceptor (by 69 %, p < 0.05) mRNA levels in the rats 
exposed to CUMS. Melatonin increased gene expression of α1-
adrenoceptor in CUMS group (60 %, p < 0.05) (Fig. 1a). Exposure 
of the rats to CUMS decreased protein levels of α1-adrenoceptor (by 
80 %, p < 0.05) and α2-adrenoceptor (by 69 %, p < 0.05). Melatonin 
treatment induced an increase of α1-adrenoceptor protein levels 
(by 43 %, p < 0.05) in the hippocampus of stressed rats, without 
affecting α2-adrenoceptor protein content (Fig. 1b).
No significant differences in the levels of mRNA β1-
adrenoceptors and protein levels between the placebo and stressed 
groups were found. Chronic treatment with melatonin did not change 
β1-adrenoceptors gene expression and protein levels (Fig. 2a). 
Two-way ANOVA demonstrated a signifi cant effect of both 
CUMS (F(1,23) = 15.55, p < 0.001) and the melatonin treatment (F(1,23) 
= 7.93, p < 0.05) on β2-adrenoceptors mRNA. Stress decreased 
mRNA (by 49 %, p < 0.01) levels of this adrenergic receptor. On 
the other hand, melatonin treatment increased β2-adrenoceptor 
mRNA (by 74 %, p < 0.01) in the stressed rats. Two-way ANO-
VA also showed a signifi cant interaction between treatment and 
stress (F(1,23) = 8.78, p < 0.01) on β2-adrenoceptors protein levels. 
Post hoc testing showed that while stress produced a signifi cant 
reduction in protein content of this adrenergic receptor (by 33 %, 
p < 0.05), melatonin treatment prevented that CUMS-induced 
decrease (Fig. 2b).
Discussion
Since α- and β-adrenoceptors are involved in the regulation 
of a variety of mental and bodily functions, it can be assumed 
that stress-induced changes in the central adrenoceptors system 
constitute a molecular basis for physiological changes in stressed 
individuals. α1- and α2-adrenoceptors are supposed to be important 
regulatory elements in responses to stress. Previous studies in male 
tree shrews showed that chronic psychosocial stress down-regu-
lated biding sites for α2-adrenergic ligands in several brain stem 
nuclei such as: reduced α2A-adrenoceptor mRNA expression in lo-
cus coeruleus, solitary tract neurons and neurons of lateral reticu-
lar nucleus (17). Similarly, repeated stress signifi cantly decreased 
mRNA levels for α1-adrenoceptors in midbrain and hypothalamus 
(18). Our results are consistent with previous work demonstrating 
a decreased gene expression of α1- and α2-adrenoceptors in the hip-
pocampus of rats subjected to unpredictable chronic mild stress. 
The mammalian hippocampus receives noradrenergic innerva-
tion and hippocampal neurons express β1- and β2-adrenoceptors. 
Both type of receptors are localized to the cell membrane and cy-
toplasm, however only β2-adrenoceptors are found in the nucleus 
(19). The data presented here showed that CUMS caused a decrease 
of β2-adrenoceptors mRNA and protein levels, while there was no 
change in gene expression of β1- in the hippocampus. Our results 
are consistent with Flügge et al (20), who reported that repeated 
exposure to subordination stress down-regulated β-adrenoceptors 
expression in the hippocampus. α1- and α2-adrenoreceptors and 
their signaling system were important targets of antidepressant 
drugs (21). Kreiner et al (22) reported that in contrast to imipra-
mine and electroconvulsive shock, which produce up-regulation of 
the α1A-adrenoceptors mRNA expression, chronically administered 
citalopram did not affect the α1A-adrenoceptors mRNA level in the 
prefrontal cortex. Our observations indicated that melatonin treat-
ment in the CUMS rats prevented the stress-induced decrease in α1-
mRNA and protein levels. On the other hand, melatonin treatment 
did not affect either mRNA or protein level of α2-adrenoceptors 
in the hippocampus of rats exposed to CUMS. Given that Stone 
and co-workers (23) reported that brain α1-adrenoceptors were 
impaired or inhibited in depressed patients or after stress in ani-
mal models, and were restored by a number of antidepressants, it 
is possible that melatonin mediated antidepressant-like effect by 
modulating the gene expression of α1-adrenoceptors in the hip-
pocampus of CUMS rats. 
Although α-adrenoceptors can infl uence hippocampal function, 
largely through regulating neuronal excitability, β -adrenocep-
tors exert very specifi c effects on synaptic information encond-
ing (24). Our data revealed that melatonin treatment prevented 
stress-induced decrease in the expression of β2-adrenoceptors in 
hippocampus of CUMS rats. β-adrenoceptors in hippocampus play 
an important role in regulating synaptic plasticity and memory 
consolidation. The activation of these adrenoceptors results in 
the stimulation of extracellular signal-regulated kinase/mitogen-
activated protein kinase (ERK/MAPK) that is a key step in the 
activation of the cAMP response element-binding protein (CREB) 
that mediates protein transcription and thus strongly supports per-
sistent synaptic plasticity and long-term memory (25). Maity et al 
(26) reported that norepinephrine activating β-adrenoceptors could 
boost long-term potentiation, a putative cellular mechanism for 
memory formation. The hippocampus-dependent memory is im-
paired following a reduction of norepinephrine or after blockade 
of β-adrenoceptors (27). Taken together, it gives rise to the possi-
bility that melatonin-induced up-regulation of gene expression of 
β2-adrenoceptors in the hippocampus of CUMS rats could enhance 
long-term potentiation and learning and memory. Our fi ndings here 
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provide novel targets for exploring the molecular mechanisms by 
which melatonin is improving mental health modulating through 
dysfunctional noradrenergic synaptic transmission. Recently, we 
reported that reduced noradrenaline content was increased in the 
hippocampus of stressed rats treated with melatonin (28). The pres-
ent results suggested that repeated treatment with melatonin might 
improve a reduced expression of α1- and β2-adrenoreceptors, and 
it was in a good correlation with increased noradrenaline in the 
hippocampus. Although the molecular basis of the gene regulation 
of α- and β-adrenoceptors in the hippocampus of rats exposed to 
CUMS during melatonin treatment remains to be elucidated, in-
creased gene expression of α1- and β2-adrenoceptors provides an 
experimental opportunity to probe into further molecular mecha-
nisms underlying the regulation of these receptor subtype. Further 
ex periments on transcriptional activation and mRNA stabil ity will 
be required to unravel the complexity of stress- and melatonin-
dependent regulation of α- and β-adrenoceptor gene expression.
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